The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
To accelerate the development of next-generation radioconjugates to treat cancer
A five-day inspection was concluded successfully with no critical and no major observations raised
Additional capacity broadens Grace’s fine chemical capabilities for API production
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
More than 10,000 scientific publications containing EUDRAGIT
Subscribe To Our Newsletter & Stay Updated
